Protagonist Therapeutics, Inc. (PTGX)

79.06 -1.16 (-1.45%) USD  |  NASDAQ  |  Jan 12, 10:53
More

Protagonist Therapeutics EBITDA Margin (TTM)

EBITDA Margin (TTM) Chart

View EBITDA Margin (TTM) for PTGX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA Margin (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Margin (TTM) Range, Past 5 Years

View EBITDA Margin (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA Margin (TTM) Benchmarks

View EBITDA Margin (TTM) Benchmarks
Start Trial
Johnson & Johnson Upgrade
ADMA Biologics, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
MannKind Corp. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade